Discovery and structure–activity relationship studies of quinolinone derivatives as potent IL-2 suppressive agents

Add time:08/06/2019    Source:sciencedirect.com

The quinolinone skeleton has been utilized to develop various mechanism-based immune modulators. However, the effects of quinolinone derivatives on the release of T cell-associated interleukin-2 (IL-2) have not been established. In this study, a series of novel quinolinone derivatives was synthesized, and their immunosuppressive activity was evaluated by measuring suppression of IL-2 release from activated Jurkat T cells. Optimizing the three side chains around the quinolinone skeleton revealed the most active compound: 11l. This compound exhibits potent inhibitory activity toward IL-2 release in both 12-o-tetradecanoylphorbol-13-acetate (PMA)/A23187 (ionomycin) (IC50 = 80 ± 10 nM) and anti-CD3/CD28-stimulated Jurkat T cells (83% inhibition at 10 μM) without cytotoxic effects. Further investigation into the underlying mechanism of 11l indicated the suppression of NF-κB and nuclear factor of activated T cells (NFAT) promoter activities in Jurkat T cells.

We also recommend Trading Suppliers and Manufacturers of 2-(3-METHOXY-4-BROMOPHENYL)ETHYLAMINE (cas 113081-51-9). Pls Click Website Link as below: cas 113081-51-9 suppliers

Prev:Synthesis, spectroscopy, catalysis and crystal structure of [Rh(η4-cod){(R)-N-(Ar)ethyl-2-oxo-1-naphthaldiminato-κ2N,O}] (Ar = C6H5, 3-/4-MeOC6H4, and 4-BrC6H4)
Next:Factorial designs in ophthalmic formulation development of Enalkiren (cas 113082-98-7))